General Surgery Coding Alert - 2021 Issue 19
Fraud & Abuse: Feds Fixate on Drug Fraud in Fall Enforcement
Subscribe or sign in to view the full article.
Article Overview
This article summarizes several recent federal criminal and civil enforcement actions focused on alleged prescription-drug fraud involving physicians and related medical professionals. It is relevant to compliance staff, coders, auditors, and healthcare administrators who track fraud-and-abuse risk, controlled-substance enforcement, and allegations involving Medicare, Medicaid, and private insurance. The piece presents a case-by-case overview of the enforcement trends and the general categories of allegations discussed in each matter.
Why This Topic Matters
The article highlights current enforcement priorities in healthcare fraud and controlled-substance cases, helping readers recognize the broader compliance and audit implications for practices involved in prescribing, billing, and drug-related medical services.
Article Sections
-
Connecticut case
A federal enforcement matter involving a physician and alleged prescription-related conduct, with references to government investigation activity and insurance program billing concerns.
-
Virginia case
A reported scheme involving a physician and pharmacist arrangement tied to compounded products, insurance claims, and projected sentencing exposure.
-
Michigan case
A fraud case centered on alleged medically unnecessary procedures, opioid-related conduct, and related financial and promotional allegations.
-
Georgia case
A federal indictment involving multiple defendants and alleged controlled-substance distribution activity connected to pain-management and addiction facilities.
-
Louisiana case
An indictment describing alleged unlawful controlled-substance distribution, clinic operations, and insurance-related fraud claims.
What You Will Learn
- How recent federal enforcement actions are framing alleged prescription-drug fraud
- The types of fraud-and-abuse allegations appearing in physician-focused cases
- Which healthcare payment programs and insurers are mentioned in the reported matters
- How controlled-substance enforcement is intersecting with medical practice oversight
Who Should Read This
- Medical coders
- Compliance officers
- Healthcare auditors
- Practice managers
- Physicians
- Healthcare attorneys
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com